Hans Carl Hasselbalch

Researcher Next ID · RN-038736

Researcher · Biochemistry, Genetics and Molecular Biology

University of Copenhagen

Copenhagen, Denmark

Accepting doctoral researchersFunding unknown

Works count: 550
Citation count: 15,324
H-index: 60
i10-index: 251

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Myeloproliferative Neoplasms: Diagnosis and Treatment

Eosinophilic Disorders and Syndromes

Chronic Myeloid Leukemia Treatments

Acute Myeloid Leukemia Research

Kruppel-like factors research

Publications

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
The Lancet · 2023 · https://doi.org/10.1016/s0140-6736(22)02036-0
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
The Lancet Haematology · 2020 · https://doi.org/10.1016/s2352-3026(19)30236-4
Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet
Leukemia · 2018 · https://doi.org/10.1038/s41375-018-0077-1
Classification and Personalized Prognosis in Myeloproliferative Neoplasms
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1716614
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both
Leukemia · 2016 · https://doi.org/10.1038/leu.2016.12
Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet
Journal of Clinical Oncology · 2011 · https://doi.org/10.1200/jco.2010.31.8436
Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference
Blood · 2009 · https://doi.org/10.1182/blood-2008-09-176818
A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis: results of a European LeukemiaNet (ELN) consensus process
British Journal of Haematology · 2009 · https://doi.org/10.1111/j.1365-2141.2009.08019.x
MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort
Blood · 2008 · https://doi.org/10.1182/blood-2008-01-131664
Incidence, clinical features and outcome of essential thrombocythaemia in a well defined geographical area
European Journal Of Haematology · 2000 · https://doi.org/10.1034/j.1600-0609.2000.90236.x

Current projects

No projects listed.